Townsend & Associates, Inc Abb Vie Inc. Transaction History

Townsend & Associates, Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	SELL	$137.62 - $174.96 $1.89 Million - $2.41 Million	-13,747 Closed	0 $0
Q1 2022 Apr 14, 2022	BUY	$131.98 - $163.75 $141,746 - $175,867	1,074 Added 8.47%	13,747 $2.41 Million
Q4 2021 Jan 18, 2022	BUY	$107.43 - $135.93 $1.36 Million - $1.72 Million	12,673 New	12,673 $1.72 Million
Q4 2018 Jan 15, 2019	SELL	$77.85 - $96.01 $945,643 - $1.17 Million	-12,147 Closed	0 $0
Q3 2018 Oct 29, 2018	BUY	$88.91 - $98.84 $220,674 - $245,320	2,482 Added 25.68%	12,147 $1.15 Million
Q2 2018 Jul 19, 2018	BUY	$89.78 - $106.23 $59,703 - $70,642	665 Added 7.39%	9,665 $895,000
Q1 2018 Apr 17, 2018	BUY	$92.01 - $123.21 $81,980 - $109,780	891 Added 10.99%	9,000 $852,000
Q4 2017 Feb 15, 2018	BUY	$89.56 - $98.21 $34,122 - $37,418	381 Added 4.93%	8,109 $784,000
Q4 2017 Jan 26, 2018	BUY	$89.56 - $98.21 $692,119 - $758,966	7,728	7,728 $687,000

4,111

1.28B

16.7M

15M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $363B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Townsend & Associates, Inc, based on Form 13F filings with the SEC.

Stay updated on Townsend & Associates, Inc with notifications on news.